来自MSN3 分钟
Alzheimer’s breakthrough after drug treatment success
Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s. Scientists have now created a drug ...
health.economictimes.indiatimes6 分钟
EU withdraws marketing authorisation for Abbvie's hepatitis C drug
The drug, also known as dasabuvir, was granted authorisation in the European Union in January 2015 for the treatment of chronic hepatitis C, a liver disease caused by a bloodborne virus.
Woman Begged Scientologist Doctor For Mental Health Treatment Before Suicide, Lawsuit Says
Dr. David Minkoff, a high-ranking Scientologist, is accused by Whitney Mills’ family of depriving her of psychiatric ...
centerforbiosimilars16 分钟
Eye on Pharma: High Strength Trastuzumab Biosimilar; Originator Coverage Removals; CHMP ...
The FDA approved a new strength of a trastuzumab biosimilar; UnitedHealth will remove reference adalimumab from some ...
Ninth Circuit Decision Marks Critical Legal Victory for U.S. FDA in Mission to Protect ...
The International Society for Cell & Gene Therapy (ISCT) celebrates a major legal victory in the ongoing fight to protect the ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly ...
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
New study is a promising ‘first’ in Alzheimer’s drug development
Researchers believe their work will have a significant impact on drug discovery efforts in the field of neurodegenerative ...